Elevated serum IgE against MGL_1304 in patients with atopic dermatitis and cholinergic urticaria

Allergology International

Volumn 63, Issue 1, 2014, Pages 83-93

  Hiragun, Makiko ^a   Hiragun, Takaaki ^a   Ishii, Kaori ^a   Suzuki, Hidenori ^a,b   Tanaka, Akio ^a   Yanase, Yuhki ^a   Mihara, Shoji ^a   Haruta, Yoshinori ^a   Kohno, Nobuoki ^a   Hide, Michihiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Hiroshima Bunkyo Women's College   (Japan)

Author keywords

Atopic dermatitis; Cholinergic urticaria; ELISA; Malassezia globosa; MGL 1304

Indexed keywords

FUNGAL PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; MGL 1304 PROTEIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLERGIC DISEASE; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BASOPHIL; CHILD; CHOLINERGIC URTICARIA; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; FEMALE; HISTAMINE RELEASE; HUMAN; IMMUNOBLOTTING; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALASSEZIA GLOBOSA; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SWEAT; URTICARIA; WESTERN BLOTTING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLERGENS; ANTIBODY SPECIFICITY; BASOPHILS; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SWEAT; URTICARIA; YOUNG ADULT;

EID: 84896879842     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.13-OA-0611     Document Type: Article

References (28)

1. Ring J, Alomar A, Bieber T et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol 2012;26:1045-60.
2. Ring J, Alomar A, Bieber T et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol 2012;26:1176-93.
3. Katayama I, Kohno Y, Akiyama K et al. Japanese guideline for atopic dermatitis. Allergol Int 2011;60:205-20.
4. Kim DH, Park KY, Kim BJ, Kim MN, Mun SK. Antiimmunoglobulin E in the treatment of refractory atopic dermatitis. Clin Exp Dermatol 2012;38:496-500.
5. Quist SR, Ambach A, Goppner D et al. Long-term treatment of severe recalcitrant atopic dermatitis with omalizumab, an anti-immuno-globulin E. Acta Derm Venereol 2013;93:206-8.
6. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441-6.
7. McAleer MA, Irvine AD. The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol 2013; 131:280-91.
8. Adachi J, Aoki T, Yamatodani A. Demonstration of sweat allergy in cholinergic urticaria. J Dermatol Sci 1994;7:142-9.
9. Hide M, Tanaka T, Yamamura Y, Koro O, Yamamoto S. IgE-mediated hypersensitivity against human sweat antigen in patients with atopic dermatitis. Acta Derm Venereol 2002;82:335-40.
10. Fukunaga A, Bito T, Tsuru K et al. Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes. J Allergy Clin Immunol 2005; 116:397-402.
11. Kameyoshi Y, Tanaka T, Mochizuki M et al. [Taking showers at school is beneficial for children with severer atopic dermatitis]. Arerugi 2008;57:130-7 (in Japanese).
12. Murota H, Takahashi A, Nishioka M et al. Showering reduces atopic dermatitis in elementary school students. Eur J Dermatol 2010;20:410-1.
13. Tanaka A, Tanaka T, Suzuki H, Ishii K, Kameyoshi Y, Hide M. Semi-purification of the immunoglobulin E-sweat antigen acting on mast cells and basophils in atopic dermatitis. Exp Dermatol 2006;15:283-90.
14. Takahagi S, Tanaka T, Ishii K et al. Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis. Br J Dermatol 2009;160:426-8.
15. Hiragun T, Ishii K, Hiragun M et al. Fungal protein MGL_ 1304 in sweat is an allergen for atopic dermatitis patients. J Allergy Clin Immunol 2013;132:608-15. e4.
16. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4.
17. Shindo H, Ishii K, Yanase Y, Suzuki H, Hide M. Histamine release-neutralization assay for sera of patients with atopic dermatitis and/or cholinergic urticaria is useful to screen type I hypersensitivity against sweat antigens. Arch Dermatol Res 2012;304:647-54.
18. Kakinuma T, Nakamura K, Wakugawa M et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001;107:535-41.
19. Darabi K, Hostetler SG, Bechtel MA, Zirwas M. The role of Malassezia in atopic dermatitis affecting the head and neck of adults. J AmAcad Dermatol 2009;60:125-36.
20. Sonesson A, Bartosik J, Christiansen J et al. Sensitization to skin-associated microorganisms in adult patients with atopic dermatitis is of importance for disease severity. Acta Derm Venereol 2013;93:340-5.
21. Zhang E, Tanaka T, Tajima M et al. Anti-Malasseziaspecific IgE antibodies production in Japanese patients with head and neck atopic dermatitis: Relationship between the level of specific IgE antibody and the coloniza tion frequency of cutaneous Malassezia species and clinical severity. J Allergy (Cairo) 2011;2011:645670.
22. Ishibashi Y, Kato H, Asahi Y, Sugita T, Nishikawa A. Identification of the major allergen of Malassezia globosa relevant for atopic dermatitis. J Dermatol Sci 2009;55:185-92.
23. Tanaka T, Ishii K, Suzuki H, Kameyoshi Y, Hide M. [Cholinergic urticaria successfully treated by immunotherapy with partially purified sweat antigen]. Arerugi 2007;56:54-7.
24. Kozaru T, Fukunaga A, Taguchi K et al. Rapid desensitization with autologous sweat in cholinergic urticaria. Allergol Int 2011;60:277-81.
25. Bito T, Sawada Y, Tokura Y. Pathogenesis of cholinergic urticaria in relation to sweating. Allergol Int 2012;61:539-44.
26. Scadding GW, Shamji MH, Jacobson MR et al. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin Efacilitated allergen binding to B cells. Clin Exp Allergy 2010;40:598-606.
27. Klimek L, Schendzielorz P, Pinol R, Pfaar O. Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study. Clin Exp Allergy 2012;42:936-45.
28. Zhang E, Tanaka T, Tsuboi R, Makimura K, Nishikawa A, Sugita T. Characterization of Malassezia microbiota in the human external auditory canal and on the sole of the foot. Microbiol Immunol 2012;56:238-44.